Hormones & Decision Making

Clinical Trial Description

This study will investigate the influence of reward sensitivity on cheating behavior via experimental manipulation of reward sensitivity using testosterone. ;

Study Design

See also
Status	Clinical Trial	Phase
Recruiting	`NCT00060788` - Antisocial Behavior: Passing From Parent to Child to Grandchild	N/A
Completed	`NCT00000388` - Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA)	Phase 4
Withdrawn	`NCT02361177` - Role of Oxytocin in Telling and Detecting Lies	Phase 0

See also

Status

Clinical Trial

Phase

Recruiting

NCT00060788 - Antisocial Behavior: Passing From Parent to Child to Grandchild

N/A

Completed

NCT00000388 - Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA)

Phase 4

Withdrawn

NCT02361177 - Role of Oxytocin in Telling and Detecting Lies

Phase 0

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04865562
Study type	Interventional
Source	University of Texas at Austin
Contact
Status	Completed
Phase	Phase 4
Start date	March 1, 2015
Completion date	September 1, 2016

Hormones and Decision Making

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms